Follow-The-Filings

Security

Corvus Pharmaceuticals Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

7 owners 1 new 3 exits max 0.0% (Ancora Advisors LLC)

owners 7
max % 0.0%
tracked value $60M
qoq N 1 A 5 E 3

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Ancora Advisors LLC 2026 Q1 0.0% Add +0.01 pp 54,768 $801 hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Add 0.00 pp 866,362 $13M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Add +0.01 pp 548,285 $8M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Add 0.00 pp 3,873,482 $30M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add 0.00 pp 442,522 $6M hist
Renaissance Technologies LLC 2026 Q1 0.0% New 0.0% 81,310 $1M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit 0.00 pp 143,598 $1M hist
Steve Cohen - Point72 Asset Management, L.P. exited 2026 Q1 last 2025 Q4 0.0% Exit -0.02 pp 2,875,000 $22M hist
D. E. Shaw & Co., Inc. exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 64,915 $500 hist
Dmitry Balyasny - Balyasny Asset Management L.P. exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 25,031 $193 hist

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue
Gross profit
Gross margin
Net income -$27.03M -$62.29M -$15.28M
Net margin

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $27.96M $54.41M $58.21M
Total non-current assets * $17.6M $14.5M $12.9M
Total assets $45.55M $68.91M $71.12M
Total current liabilities $6.87M $35.4M $9.38M
Total non-current liabilities * $0.00 $937,000 $534,000
Total equity $38.68M $32.57M $61.2M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$23.94M -$25.42M -$32.8M
Cash from investing $15.54M -$27.48M -$7.8M
Cash from financing $7.86M $49.03M $36.43M
Net change in cash -$539,000 -$3.88M -$4.16M

ownership over time

filing count by report period · click a bar for that quarter’s holders